tradingkey.logo
搜尋

IDEAYA Biosciences Inc

IDYA
添加自選
35.500USD
-0.900-2.47%
收盤 07-31 16:00美東報價延遲15分鐘
3.38B總市值
虧損本益比TTM

股東統計

更新時間: 5月10日 週日
更新時間: 5月10日 週日
持股股東
股東類型
持股股東
持股股東
佔比
Fidelity Management & Research Company LLC
14.97%
Janus Henderson Investors
8.18%
BlackRock Institutional Trust Company, N.A.
7.45%
Capital Research Global Investors
6.01%
State Street Investment Management (US)
4.71%
其他
58.69%
持股股東
持股股東
佔比
Fidelity Management & Research Company LLC
14.97%
Janus Henderson Investors
8.18%
BlackRock Institutional Trust Company, N.A.
7.45%
Capital Research Global Investors
6.01%
State Street Investment Management (US)
4.71%
其他
58.69%
股東類型
持股股東
佔比
Investment Advisor
49.16%
Investment Advisor/Hedge Fund
34.40%
Hedge Fund
18.19%
Venture Capital
4.64%
Research Firm
3.40%
Corporation
1.52%
Individual Investor
0.89%
Pension Fund
0.86%
Bank and Trust
0.43%

機構持股

更新時間: 4月1日 週三
更新時間: 4月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q1
518
97.55M
111.03%
-12.93M
2025Q4
494
96.98M
110.62%
-16.62M
2025Q3
460
105.73M
120.62%
-11.57M
2025Q2
449
101.70M
116.06%
-6.32M
2025Q1
454
97.81M
111.68%
-11.15M
2024Q4
442
95.26M
108.96%
-7.87M
2024Q3
426
95.20M
112.79%
+2.56M
2024Q2
409
85.26M
112.59%
-3.91M
2024Q1
388
81.45M
108.91%
-1.44M
2023Q4
351
68.31M
105.94%
-512.62K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Fidelity Management & Research Company LLC
13.15M
14.97%
+3.42K
+0.03%
Dec 31, 2025
Janus Henderson Investors
7.19M
8.18%
+758.12K
+11.79%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
6.54M
7.45%
+208.10K
+3.28%
Dec 31, 2025
Capital Research Global Investors
5.28M
6.01%
-1.27M
-19.43%
Dec 31, 2025
State Street Investment Management (US)
4.13M
4.71%
+893.71K
+27.58%
Dec 31, 2025
Baker Bros. Advisors LP
3.62M
4.12%
+343.38K
+10.48%
Dec 31, 2025
Logos Global Management LP
3.13M
3.56%
+875.00K
+38.89%
Dec 31, 2025
Federated Hermes Global Investment Management Corp.
3.40M
3.87%
-1.23M
-26.59%
Dec 31, 2025
Adage Capital Management, L.P.
2.80M
3.19%
-100.09K
-3.45%
Dec 31, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Tema Oncology ETF
3.49%
ALPS Medical Breakthroughs ETF
1.16%
Virtus LifeSci Biotech Clinical Trials ETF
0.97%
Invesco Dorsey Wright Healthcare Momentum ETF
0.83%
State Street SPDR S&P Biotech ETF
0.72%
First Trust Innovation Leaders ETF
0.7%
Direxion Daily S&P Biotech Bull 3X Shares
0.45%
ProShares Ultra Nasdaq Biotechnology
0.38%
Avantis US Small Cap Equity ETF
0.29%
Invesco Nasdaq Biotechnology ETF
0.27%
查看更多
Tema Oncology ETF
佔比3.49%
ALPS Medical Breakthroughs ETF
佔比1.16%
Virtus LifeSci Biotech Clinical Trials ETF
佔比0.97%
Invesco Dorsey Wright Healthcare Momentum ETF
佔比0.83%
State Street SPDR S&P Biotech ETF
佔比0.72%
First Trust Innovation Leaders ETF
佔比0.7%
Direxion Daily S&P Biotech Bull 3X Shares
佔比0.45%
ProShares Ultra Nasdaq Biotechnology
佔比0.38%
Avantis US Small Cap Equity ETF
佔比0.29%
Invesco Nasdaq Biotechnology ETF
佔比0.27%
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有